Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Glomerular accumulation of extracellular matrix is a prominent feature of progressive glomerulonephritis. Previously, we have shown that transforming growth factor-beta (TGF-beta) is unique among growth factors in regulating the production of the proteoglycans biglycan and decorin by glomerular mesangial cells in vitro. We now provide evidence of an elevated expression of TGF-beta, proteoglycans, and fibronectin in glomerulonephritis induced in rats by injection of anti-thymocyte serum (ATS). Glomeruli were cultured from rat kidneys at 1, 4, 7, 14, and 28 d after ATS administration. Increased proteoglycan synthesis was detected beginning on day 4, which peaked at a 4,900% increase compared with control on day 7, and returned toward control levels by day 28. The increased proteoglycan synthesis by cultured nephritic glomeruli, as well as that of fibronectin, were greatly reduced by addition of antiserum raised against a synthetic peptide from TGF-beta. Conditioned media from ATS glomerular cultures, when added to normal cultured mesangial cells, induced elevated proteoglycan synthesis that also peaked on day 7 and that mimicked the response to added exogenous TGF-beta. The stimulatory activity of the conditioned media was blocked by addition of TGF-beta antiserum. Prior addition of the immunizing peptide to the antiserum abolished the blocking effect. The main induced proteoglycans were identified as biglycan and decorin by immunoprecipitation with antiserum made against synthetic peptides from the proteoglycan core proteins. Glomerular histology showed mesangial matrix expansion in a time course that roughly paralleled both the elevated proteoglycan synthesis by the ATS glomeruli and the ability of the conditioned media from these glomeruli to induce proteoglycan synthesis. At the same time there was an increased expression of TGF-beta mRNA and TGF-beta protein in the glomeruli. These results suggest a central role for TGF-beta in the accumulation of pathological extracellular matrix in glomerulonephritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-b1 induces the synthesis of decorin and biglycan.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725 · cited 1×
“Total RNA was prepared by lysis of isolated glomeruli in guanidine isothiocyanate and ultracentrifugation of lysate on a cesium chloride cushion (30).”
MethodRoberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866 · cited 1×
“There is now growing evidence that some of TGF-#'s multiple actions (3) are mediated through regulatory effects on: (a) extracellular matrix synthesis (6-8), (b) enzymes that degrade extracellular matrix (9, 10), and (c) the expression of extracellular matrix receptors on cells (1 1).”
BackgroundIgnotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Fort, P., Marty, L., Piechaczyk, M., Sabrouty, S. E., Dani, C., Jeanteur, P., & Blanchard, J. M. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.5.1431 · Cited by 2,099 · cited 1×
“A porcine TGF-#3I cDNA probe (31) and a rat glyceraldehyde-3-phosphate dehydrogenase cDNA probe (32), kindly provided by Dr.”
MethodEdwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221 · cited 1×
“There is now growing evidence that some of TGF-#'s multiple actions (3) are mediated through regulatory effects on: (a) extracellular matrix synthesis (6-8), (b) enzymes that degrade extracellular matrix (9, 10), and (c) the expression of extracellular matrix receptors on cells (1 1).”
BackgroundTransforming Growth Factor-β: Biological Function and Chemical Structure
Sporn, M. B., Roberts, A. B., Wakefield, L. M., & Assoian, R. K. (1986) · Science · doi:10.1126/science.3487831 · Cited by 1,182
Wound Macrophages Express TGF-α and Other Growth Factors in Vivo: Analysis by mRNA Phenotyping
Rappolee, D. A., Mark, D., Banda, M. J., & Werb, Z. (1988) · Science · doi:10.1126/science.3041594 · Cited by 1,104 · cited 1×
“Macrophages, at the site of experimental wounds, are known to contain TGF-# mRNA (46).”
BackgroundVogel, K. G., Paulsson, M., & Heinegård, D. (1984) · Biochemical Journal · doi:10.1042/bj2230587 · Cited by 856 · cited 1×
“Decorin, one ofthe proteoglycans regulated by TGF-f3, is known to bind fibronectin and collagen (43, 44) in addition to be involved in the control of cell proliferation (45).”
BackgroundThe Progression of Renal Disease
Epstein, F. H., Klahr, S., Schreiner, G., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182505 · Cited by 828
Structure and Biology of Proteoglycans
Ruoslahti, E. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001305 · Cited by 713 · cited 2×
“However, in contrast to TGF-,B, we (17) and others (35, 42) have found no evidence that these growth factors significantly affect matrix synthesis.”
BackgroundResultSelf-citation
Research works printed but not linked: 1
- Chen, J. K., H. Hoshi, and W. L. McKeehan. 1987. Trans- forming growth factor ,B specifically stimulates synthesis of proteogly- can in human adult arterial smooth muscle cells. Proc. Nati. Acad. Sci. USA. 84:5287-5291.
Cited by
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Self-citationTGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Interactions between extracellular matrix and growth factors in wound healing
Schultz, G. S., & Wysocki, A. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00466.x · Cited by 1,126
“TGF- b1 induces the synthesis of decorin and biglycan.(47) Conversely, binding of TGF-b1 to decorin, betaglycan, and biglycan inhibits its activity, suggesting a negative feedback loop.”
BackgroundTransforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Self-citationKagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Self-citationBorder, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. (1992) · Nature · doi:10.1038/360361a0 · Cited by 974
Self-citationYamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
Self-citationBroekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
Roberts, A. B., & Sporn, M. B. (1993) · Growth Factors · doi:10.3109/08977199309029129 · Cited by 755
Sanderson, N., Factor, V, Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., & Thorgeirsson, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2572 · Cited by 671
Transforming growth factor βs and wound healing
O'Kane, S., & Ferguson, M. W. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00120-3 · Cited by 634
Branton, M. H., & Kopp, J. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00250-6 · Cited by 603
Muscle injuries and repair: current trends in research.
Huard, J., Li, Y., & Fu, F. H. (2002) · PubMed · Cited by 604
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
Isaka, Y., Fujiwara, Y., Ueda, N., Kaneda, Y., Kamada, T., & Imai, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116874 · Cited by 529
MUSCLE INJURIES AND REPAIR: CURRENT TRENDS IN RESEARCH
HUARD, J., LI, Y., & FU, F. H. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200205000-00022 · Cited by 522
Dynamic reciprocity in the wound microenvironment
Schultz, G. S., Davidson, J. M., Kirsner, R. S., Bornstein, P., & Herman, I. M. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00673.x · Cited by 490
“TGF-b1 induces the synthesis of decorin and biglycan.(88) Binding of TGF-b1 to decorin, betaglycan, and biglycan inhibits its activity, suggesting a negative feedback loop.”
BackgroundGene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Self-citationPolygenic control of susceptibility to murine systemic lupus erythematosus
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., & Wakeland, E. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90100-7 · Cited by 471
IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y. (1997) · Biochemical Journal · doi:10.1042/bj3220809 · Cited by 445
Thannickal, V. J., & Fanburg, B. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30334 · Cited by 424
Huang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423
Self-citationExpression of transforming growth factor-β isoforms in human glomerular diseases
Yamamoto, T., Noble, N. A., Cohen, A. H., Nast, C. C., Hishida, A., Gold, L. I., & Border, W. A. (1996) · Kidney International · doi:10.1038/ki.1996.65 · Cited by 418
Self-citationTransforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414
Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis
Yamamoto, T., Noble, N. A., Miller, D. E., & Border, W. A. (1994) · Kidney International · doi:10.1038/ki.1994.122 · Cited by 405
Self-citationFloege, J., Burns, M. W., Alpers, C. E., Yoshimura, A., Pritzl, P., Gordon, K., Seifert, R. A., Bowen-Pope, D. F., Couser, W. G., & Johnson, R. J. (1992) · Kidney International · doi:10.1038/ki.1992.42 · Cited by 404
The impact of gender on the progression of chronic renal disease
Silbiger, S. R., & Neugarten, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90119-1 · Cited by 393
Wolf, G., Mueller, E., Stahl, R. A., & Ziyadeh, F. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116710 · Cited by 379
TGF-β in kidney fibrosis: A target for gene therapy
Border, W. A., & Noble, N. A. (1997) · Kidney International · doi:10.1038/ki.1997.190 · Cited by 379
Self-citationHigh glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β
Wolf, G., Sharma, K., Chen, Y., Ericksen, M., & Ziyadeh, F. N. (1992) · Kidney International · doi:10.1038/ki.1992.330 · Cited by 356
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
Matsumoto, K., & Nakamura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00717.x · Cited by 353
TGF-β in Renal Injury and Disease
Böttinger, E. P. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.009 · Cited by 339
Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A., Rochelle, J. M., & Seldin, M. F. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1645 · Cited by 338
Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A., & Boor, P. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-4 · Cited by 337
“However, during progressive renal scarring an increased expression of decorin and biglycan was observed in various experimental models of renal injury and in humans [79,84,85,89-91].”
BackgroundGeorge, J., Roulot, D., Koteliansky, V. E., & Bissell, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12719 · Cited by 322
Cellular events in the evolution of experimental diabetic nephropathy
Young, B. A., Johnson, R. J., Alpers, C. E., Eng, E., Gordon, K., Floege, J., Couser, W. G., & Seidel, W. T. S. A. F. S. K. (1995) · Kidney International · doi:10.1038/ki.1995.139 · Cited by 318
Gurujeyalakshmi, G., & Giri, S. N. (1995) · Experimental Lung Research · doi:10.3109/01902149509050842 · Cited by 303
NAD(P)H Oxidase Mediates TGF-β1–Induced Activation of Kidney Myofibroblasts
Bondi, C. D., Manickam, N., Lee, D. Y., Block, K., Gorin, Y., Abboud, H. E., & Barnes, J. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009020146 · Cited by 297
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
Voelker, J., Berg, P. H., Sheetz, M., Duffin, K., Shen, T., Moser, B., Greene, T., Blumenthal, S. S., Rychlik, I., Yagil, Y., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111230 · Cited by 275
Heilig, C. W., Concepcion, L. A., Riser, B. L., Freytag, S. O., Zhu, M., & Cortes, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118226 · Cited by 271
Extracellular Matrix and Cytokines: A Functional Unit
Schönherr, E., & Hausser, H.-J. (2000) · Journal of Immunology Research · doi:10.1155/2000/31748 · Cited by 268
Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule
Rocco, M. V., Chen, Y., Goldfarb, S., & Ziyadeh, F. N. (1992) · Kidney International · doi:10.1038/ki.1992.14 · Cited by 265
Increased synthesis of extracellular matrix in mesangial proliferative nephritis
Floege, J., Johnson, R. J., Gordon, K., Iida, H., Pritzl, P., Yoshimura, A., Campbell, C., Alpers, C. E., & Couser, W. G. (1991) · Kidney International · doi:10.1038/ki.1991.235 · Cited by 264
Targeting TGF-β Signaling in Kidney Fibrosis
Isaka, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092532 · Cited by 252
“TGF-β up-regulates the synthesis of individual matrix components, including collagens, proteoglycans, and glycoproteins [2].”
Nakamura, T., Miller, D., Ruoslahti, E., & Border, W. A. (1992) · Kidney International · doi:10.1038/ki.1992.183 · Cited by 247
“proteoglycan and fibronectin production by isolated nephritic glomeruli in culture [13].”
BackgroundSelf-citationHuang, Y., Noble, N. A., Zhang, J., Xu, C., & Border, W. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002243 · Cited by 235
Self-citationStriekland, D. K., Ashcom, J. D., Williams, S., Battey, F., Behre, E., McTigue, K., Battey, J. F., & Argraves, W. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98848-4 · Cited by 229
The glomerular response to injury: Progression or resolution?
Johnson, R. J. (1994) · Kidney International · doi:10.1038/ki.1994.230 · Cited by 226
The activated mesangial cell: a glomerular "myofibroblast"?
Johnson, R. J., Floege, J., Yoshimura, A., Iida, H., Couser, W. G., & Alpers, C. E. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v210s190 · Cited by 223
Peters, H., Border, W. A., & Noble, N. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00164.x · Cited by 221
“Glomeruli from individual rats were isolated by a graded sieving technique (150, 125, 106 and 75 mm mesh metal sieves) as described previousl”
MethodSelf-citationCardiac fibrosis and inflammation interaction with hemodynamic and hormonal factors
Nicoletti, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00305-8 · Cited by 219
Akagi, Y., Isaka, Y., Arai, M., Kaneko, T., Takenaka, M., Moriyama, T., Kaneda, Y., Ando, A., Orita, Y., Kamada, T., et al. (1996) · Kidney International · doi:10.1038/ki.1996.297 · Cited by 200
Stevens, T., Conwell, D. L., & Zuccaro, G. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40694.x · Cited by 201
Vasoactive hormones and renal sclerosis
Egido, J. (1996) · Kidney International · doi:10.1038/ki.1996.82 · Cited by 198
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.
Lee, L. K., Meyer, T. W., Pollock, A. S., & Lovett, D. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118143 · Cited by 197
“The TGF-ps, and TGF-,61 in particular, have also been implicated in the progression of several models of glomerular disease, including immune complex-mediated glomerulonephritis (25-29), anti-”
BackgroundGlomerular matrix accumulation is linked to inhibition of the plasmin protease system
Tomooka, S., Border, W. A., Marshall, B. C., & Noble, N. A. (1992) · Kidney International · doi:10.1038/ki.1992.442 · Cited by 186
Self-citationXin, C., Ren, S., Kleuser, B., Shabahang, S., Eberhardt, W., Radeke, H., Schäfer-Korting, M., Pfeilschifter, J., & Huwiler, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312091200 · Cited by 181
Blockade of Transforming Growth Factor-β1 Accelerates Lymphatic Regeneration during Wound Repair
Avraham, T., Daluvoy, S., Zampell, J., Yan, A., Haviv, Y. S., Rockson, S. G., & Mehrara, B. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100594 · Cited by 181
Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus
Iwano, M., Kubo, A., Nishino, T., Sato, H., Nishioka, H., Akai, Y., Kurioka, H., Fujii, Y., Kanauchi, M., Shiiki, H., et al. (1996) · Kidney International · doi:10.1038/ki.1996.162 · Cited by 180
Yamamoto, Y., Maeshima, Y., Kitayama, H., Kitamura, S., Takazawa, Y., Sugiyama, H., Yamasaki, Y., & Makino, H. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1831 · Cited by 179
“The pivotal role of TGF- 1 in renal fibrosis has been well characterized (41).”
BackgroundParticipation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
Iruela‐Arispe, M. L., GORDON, K. L., Hugo, C., Duijvestijn, A. M., Claffey, K. P., Reilly, M. T., Couser, W. G., Alpers, C. E., & Johnson, R. J. (1995) · Europe PMC (PubMed Central) · Cited by 178
The extracellular regulation of growth factor action.
Flaumenhaft, R., & Rifkin, D. B. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1057 · Cited by 177
“This inhibition is of particular significance because TGF-,31 induces the expression of these small proteoglycans in certain cells (Okuda et al., 1990).”
BackgroundGrowth factors in glomerulonephritis
Abboud, H. E. (1993) · Kidney International · doi:10.1038/ki.1993.39 · Cited by 177
TGF-β isoforms in renal fibrogenesis
Yu, L., Border, W. A., Huang, Y., & Noble, N. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00162.x · Cited by 176
Self-citationScar Formation: The Spectral Nature of Fetal and Adult Wound Repair
Ferguson, M. W. J., Whitby, D. J., Shah, M., Armstrong, J., Siebert, J. W., & Longaker, M. T. (1996) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199604000-00029 · Cited by 172
Kresse, H., Hausser, H., & Schönherr, E. (1993) · Experientia · doi:10.1007/bf01923585 · Cited by 162
Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor
Iijima, K., Yoshikawa, N., Connolly, D. T., & Nakamura, H. (1993) · Kidney International · doi:10.1038/ki.1993.337 · Cited by 164
van den Born, J., van den Heuvel, L. P. W. J., Bakker, M. A. H., Veerkamp, J. H., Assmann, K. J. M., Weening, J. J., & Berden, J. H. M. (1993) · Kidney International · doi:10.1038/ki.1993.67 · Cited by 163
T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis
Blanco, P., Ueno, H., & Schmitt, N. (2016) · European Journal of Immunology · doi:10.1002/eji.201545760 · Cited by 162
The pathobiology of the mesangium
Kashgarian, M., & Sterzel, R. B. (1992) · Kidney International · doi:10.1038/ki.1992.74 · Cited by 162
Isaka, Y., Tsujie, M., Ando, Y., Nakamura, H., Kaneda, Y., Imai, E., & Hori, M. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00360.x · Cited by 158
“TGF-b stimulates synthesis of individual matrix components, including proteoglycans, collagens, and glycoprotein”
BackgroundKetteler, M., Noble, N. A., & Border, W. A. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.001431 · Cited by 151
Self-citationAbbate, M., Zoja, C., Morigi, M., Rottoli, D., Angioletti, S., Tomasoni, S., Zanchi, C., Longaretti, L., Donadelli, R., & Remuzzi, G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64495-1 · Cited by 170
TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy
Tamaki, K., Okuda, S., Ando, T., Iwamoto, T., Nakayama, M., & FUJISHIMA, M. (1994) · Kidney International · doi:10.1038/ki.1994.68 · Cited by 159
Self-citationRegulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells.
Yasuda, T., Kondo, S., Homma, T., & Harris, R. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119003 · Cited by 150
“Accumulating evidence indicates a preeminent role for TGFb in the accumulation of extracellular mesangial matrix (7, 9, 10), and an important role of TGFb in the accumulation of extracellular matrix in glomerulonephritis was demonstrated by Okuda et al.”
Poncelet, A.-C., de Caestecker, M. P., & Schnaper, H. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00680.x · Cited by 144
Effects of sex hormones on mesangial cell proliferation and collagen synthesis
Kwan, G., Neugarten, J., Sherman, M., Ding, Q., Fotadar, U., Lei, J., & SILBIGER, S. R. (1996) · Kidney International · doi:10.1038/ki.1996.425 · Cited by 148
Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo
Daniel, C., Wiede, J., Krutzsch, H. C., Ribeiro, S. M. F., Roberts, D. D., Murphy-Ullrich, J. E., & Hugo, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00395.x · Cited by 155
Laethem, J. V., Deviere, J. M., Résibois, A., Rickaert, F., Vertongen, P., Ohtani, H., Cremer, M., Miyazono, K., & Robberecht, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90152-3 · Cited by 148
Cytokines and Wound Healing: The Role of Cytokine and Anticytokine Therapy in the Repair Response
Efron, P. A., & Moldawer, L. L. (2004) · The Journal of Burn Care & Rehabilitation · doi:10.1097/01.bcr.0000111766.97335.34 · Cited by 140
Lee, B. S., & Nowak, R. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7237 · Cited by 137
A nonclassical vitamin D receptor pathway suppresses renal fibrosis
Ito, I., Waku, T., Aoki, M., Abe, R., Nagai, Y., Watanabe, T., Nakajima, Y., Ohkido, I., Yokoyama, K., Miyachi, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67804 · Cited by 146
Huang, Y., Haraguchi, M., Lawrence, D. A., Border, W. A., Yu, L. H., & Noble, N. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18038 · Cited by 134
Self-citationPaolo, S. D., Gesualdo, L., Ranieri, E., Grandaliano, G., & Schena, F. P. (1996) · Europe PMC (PubMed Central) · Cited by 133
Advanced Oxidation Protein Products Accelerate Renal Fibrosis in a Remnant Kidney Model
Li, H. Y., Hou, F. F., Zhang, X., Chen, P. Y., Liu, S. X., Feng, J., Liu, Z., Shan, Y., Wang, G. B., Zhou, Z. M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070781 · Cited by 132
“Third, chronic AOPP administration increased expression of TGF- 1, a well-documented fibrogenic growth factor that plays a major role in the pathogenesis of renal inflammation and fibrosis (43,44).”
BackgroundStimulation of pro-α1(I) collagen by TGF-β1in mesangial cells: role of the p38 MAPK pathway
Chin, B. Y., Mohsenin, A., Li, S. X., Choi, A. M. K., & Choi, M. E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f495 · Cited by 132
Extracellular matrix regulation of growth factor and protease activity
Flaumenhaft, R., & Rifkin, D. B. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90055-4 · Cited by 130
Isaka, Y., Akagi, Y., Ando, Y., Tsujie, M., Sudo, T., Ohno, N., Border, W. A., Noble, N. A., Kaneda, Y., Hori, M., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00275.x · Cited by 129
Self-citationManickam, N., Patel, M., Griendling, K. K., Gorin, Y., & Barnes, J. L. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00546.2013 · Cited by 124
“TRANSFORMING GROWTH FACTOR (TGF)- 1 is the predominant growth factor responsible for mesenchymal cell synthesis of the matrix during fibrosis (3, 14, 46).”
BackgroundKim, S. I., Kwak, J. H., Zachariah, M. S., He, Y., Wang, L., & Choi, M. E. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00485.2006 · Cited by 123
Elder, M. (1997) · KARGER eBooks · doi:10.1159/000060714 · Cited by 127
Early interstitial changes in hypertension-induced renal injury.
Mai, M., Geiger, H., Hilgers, K. F., Veelken, R. A., Mann, J. F. E., Dämmrich, J., & Luft, F. C. (1993) · Hypertension · doi:10.1161/01.hyp.22.5.754 · Cited by 122
Ruiz‐Ortega, M., González, S., Serón, D., Condom, E., Bustos, C., Largo, R., González, E., Ortíz, A., & Egido, J. (1995) · Kidney International · doi:10.1038/ki.1995.476 · Cited by 122
Brandt, J., Pippin, J. W., Schulze, M., Hänsch, G. M., Alpers, C. E., Johnson, R. J., GORDON, K. L., & Couser, W. G. (1996) · Kidney International · doi:10.1038/ki.1996.50 · Cited by 121
“Monocytes are not only involved in mediating acute glomerular injury [48] but are also potent sources of TGF/3, which has been established to mediate matrix expansion and glomeruloscierosis in this model [8, 9].”
BackgroundMechanisms of Progressive Renal Disease in Glomerulonephritis
Couser, W. G., & Johnson, R. J. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80971-1 · Cited by 121
PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis
Niemir, Z. I., Stein, H., Noronha, I. L., Krüger, C., Andrássy, K., Ritz, E., & Waldherr, R. (1995) · Kidney International · doi:10.1038/ki.1995.443 · Cited by 121
Coimbra, T. M., Wiggins, R. C., Noh, J., Merritt, S. E., & Phan, S. H. (1991) · PubMed · Cited by 131
Strøm, E. H., Banfi, G., Krapf, R., Abt, A. B., Mazzucco, G., Monga, G., Gloor, F. J., Neuweiler, J., Riess, R. H., Stosiek, P., et al. (1995) · Kidney International · doi:10.1038/ki.1995.280 · Cited by 118
Roberts, C. R. (1995) · CHEST Journal · doi:10.1378/chest.107.3_supplement.111s · Cited by 116
Metadata
- Authors
- Okuda, S., Languino, L. R., Ruoslahti, E., & Border, W. A.
- Affiliations
- University of Utah (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1990-08-01
- Volume
- 86
- Issue
- 2
- Pages
- 453-462
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC296747
- OpenAlex
- W2146559746
- Cited by
- 546
- References
- 53
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 13
- FWCI
- 34.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- Vlaamse regering
- National Institutes of Health (5p01ca028896-15, 5r35ca042507-07)
- U.S. Public Health Service (30199)
- National Cancer Institute (CA 28896, CA-42507)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- TGF-beta, glomerulonephritis, proteoglycan synthesis, biglycan, decorin, fibronectin, antithymocyte serum, mesangial cells, extracellular matrix accumulation, TGF-beta mRNA expression, conditioned medium
- MeSH terms
- Animals, Antilymphocyte Serum, Extracellular Matrix, Fibronectins, Fluorescent Antibody Technique, Glomerular Mesangium, Glomerulonephritis, Microscopy, Electron, Proteoglycans, RNA, Messenger, Blotting, Northern, Transforming Growth Factors, Culture Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.